http://www.panaceapharma.com/Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.Cancer > Research and DevelopmentPanacea's is focused on novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, stroke, Alzheimer's Disease, and Parkinson's Disease.
Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
is to discover, develop and commercialize innovative therapeutic and
diagnostic products. Our current product development focus is on novel
proteins and biochemical pathways related to cellular regulationPanacea Pharmaceuticalscellular regulationcell cycle abnormalitiesAlzheimer's DiseaseStrokeParkinson's Disease
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.
Intending to discovery, develop and commercialize novel therapies for cancer and blood cell disorders. Profile includes technology overview, investor data, and careers in Dublin, California. (Nasdaq: SUPG)
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.